Misplaced Pages

CU-CPT4a

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
CU-CPT4a
Identifiers
IUPAC name
  • (2R)-2--3-phenylpropanoic acid
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC18H13ClFNO3S
Molar mass377.81 g·mol
3D model (JSmol)
SMILES
  • C1=CC=C(C=C1)C(C(=O)O)NC(=O)C2=C(C3=C(S2)C=C(C=C3)F)Cl
InChI
  • InChI=1S/C18H13ClFNO3S/c19-15-12-7-6-11(20)9-14(12)25-16(15)17(22)21-13(18(23)24)8-10-4-2-1-3-5-10/h1-7,9,13H,8H2,(H,21,22)(H,23,24)/t13-/m1/s1
  • Key:IAASQMCXDRISAV-CYBMUJFWSA-N
This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (March 2021) (Learn how and when to remove this message)

CU-CPT4a is a drug which acts as a selective antagonist of Toll-like receptor 3 (TLR3), with an IC50 of 3.44 μM. It is used for research into the function of TRL3 and its role in inflammation, autoimmune disorders and cancer.

See also

References

  1. Martin-Gayo E, Cole MB, Kolb KE, Ouyang Z, Cronin J, Kazer SW, et al. (January 2018). "A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers". Genome Biology. 19 (1): 10. doi:10.1186/s13059-017-1385-x. PMC 5789701. PMID 29378643.
  2. Lomphithak T, Choksi S, Mutirangura A, Tohtong R, Tencomnao T, Usubuchi H, Unno M, Sasano H, Jitkaew S (October 2020). "Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma". Cell Communication and Signaling. 18 (1): 161. doi:10.1186/s12964-020-00661-3. PMC 7545934. PMID 33036630.


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: